2m 2m 2m 2m 2m 2m 2m
XOMA Rylty (XOMA)
NASDAQ
$41.68-$0.02 (-0.05%)
Price as of Jun 03, 2026 4:10 PM EDT- $523.1MMarket Cap
- 66.80%1-Year Change
- BiotechnologyIndustry
XOMA Rylty (XOMA)
$41.68-$0.02 (-0.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 52.1M +83.06% | 28.5M +498.72% | 4.8M -21.06% | 6.0M -84.21% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 52.1M +83.06% | 28.5M +498.72% | 4.8M -21.06% | 6.0M -84.21% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -1.7M -40.45% | -2.9M +1,910.49% | -143,000 -6.54% | -153,000 -10.53% | |
Depreciation and Amortization Expense | 3.0M +1,337.38% | 206,000 -77.03% | 897,000 +824.74% | 97,000 N/A | |
Total Operating Expenses | 40.8M -40.46% | 68.5M +46.90% | 46.6M +98.82% | 23.4M +13.62% | |
Operating Profit | 11.4M +128.48% | -40.0M -4.47% | -41.8M +140.31% | -17.4M -199.34% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -13.0M -5.85% | -13.8M +2,332.34% | -569,000 +23.43% | -461,000 0.00% | |
Interest Income and Expense and Net | -13.0M -5.85% | -13.8M +2,332.34% | -569,000 +23.43% | -461,000 0.00% | |
Total Nonoperating Income and Expense | 12.2M +76.82% | 6.9M +336.38% | 1.6M +437.63% | 295,000 +133.56% | |
Income before Taxes | 31.8M +263.33% | -19.5M -52.29% | -40.8M +138.51% | -17.1M -207.74% | |
Income Taxes | 103,000 +101.82% | -5.7M N/A | 0 +100.00% | -15,000 -116.48% | |
Extraordinary Items | N/A N/A | 14.3M N/A | N/A N/A | N/A N/A | |
Net Income | 31.7M +329.45% | -13.8M -66.15% | -40.8M +138.72% | -17.1M -208.27% | |
Net Income from Continuing Operations Applicable to Common | 26.2M +235.72% | -19.3M -58.33% | -46.3M +105.10% | -22.6M -383.33% | |
Basic EPS and Net Income | 1.53 +192.73% | -1.65 -59.16% | -4.04 +104.04% | -1.98 -386.96% | |
Diluted EPS and Net Income | 1.46 +188.48% | -1.65 -59.16% | -4.04 +104.04% | -1.98 -404.62% | |
Basic Weighted Average Shares | 12.1M +3.25% | 11.7M +101,905.06% | 11,471 -99.90% | 11.4M +1.11% | |
Diluted Weighted Average Shares | 18.0M +53.68% | 11.7M +101,905.06% | 11,471 -99.90% | 11.4M -6.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 82.9M -18.44% | 101.7M -33.69% | 153.3M +165.09% | 57.8M -38.04% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 82.9M -18.44% | 101.7M -33.69% | 153.3M +165.09% | 57.8M -38.04% | |
Total Current Assets | 117.3M -6.64% | 125.6M -25.82% | 169.3M +176.42% | 61.3M -36.83% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 21,000 -34.37% | 32,000 +28.00% | 25,000 +257.14% | 7,000 -46.15% | |
Total Long-Term Assets | 427,000 -77.06% | 1.9M +249.16% | 533,000 +105.00% | 260,000 -13.62% | |
Total Assets | 272.7M +23.24% | 221.3M -5.56% | 234.3M +66.90% | 140.4M -15.72% | |
Income Taxes Payable | 103,000 -98.27% | 6.0M N/A | N/A N/A | 91,000 0.00% | |
Total Short-Term Debt | 12.5M +9.94% | 11.4M +105.56% | 5.5M N/A | N/A N/A | |
Total Current Liabilities | 34.8M +42.86% | 24.4M +25.00% | 19.5M +185.99% | 6.8M -47.42% | |
Total Long-Term Debt | 96.5M -9.75% | 106.9M -9.82% | 118.5M N/A | N/A N/A | |
Total Long-Term Liabilities | 120.0M +7.33% | 111.8M -11.35% | 126.1M +1,215.54% | 9.6M +19,068.00% | |
Total Liabilities | 168.7M +21.08% | 139.4M -4.28% | 145.6M +789.42% | 16.4M -33.70% | |
Retained Earnings | -1.2B -1.26% | -1.2B +1.13% | -1.2B +3.45% | -1.2B +1.47% | |
Total Stockholders Equity | 83.9M +2.47% | 81.9M -7.66% | 88.7M -28.46% | 124.0M -12.59% | |
Total Shares Outstanding | 11.9M -0.78% | 12.0M +3.97% | 11.5M +0.36% | 11.5M +1.23% | |
Cash Flow | |||||
Cash from Operating Activities | 2.9M +120.88% | -13.7M -24.29% | -18.2M +40.99% | -12.9M -156.79% | |
Capital Expenditures | 20,000 0.00% | 20,000 +17.65% | 17,000 -99.89% | 15.2M +169,311.11% | |
Cash from Investing Activities | 50.9M +280.07% | -28.3M +3,874.54% | -711,000 -96.48% | -20.2M -23.69% | |
Dividends Paid | 5.5M 0.00% | 5.5M 0.00% | 5.5M 0.00% | 5.5M +56.39% | |
Cash from Financing Activities | -26.5M +137.83% | -11.1M -109.23% | 120.6M +2,809.35% | -4.5M -134.68% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 21.83% +115.56% | -140.33% -84.04% | -879.53% +204.41% | -288.93% -729.00% | |
Return on Assets | 12.84% +311.61% | -6.07% -72.16% | -21.79% +95.56% | -11.14% -202.94% | |
Return on Equity | 38.24% +336.06% | -16.20% -57.80% | -38.39% +198.37% | -12.87% -192.96% | |
Revenue Growth | 83.06% -83.34% | 498.72% +2,468.61% | -21.06% -75.00% | -84.21% -381.98% | |
Current Ratio | 3.37 -34.65% | 5.15 -40.65% | 8.68 -3.35% | 8.98 +20.13% | |
Cash Ratio | 2.38 -42.91% | 4.17 -46.95% | 7.86 -7.31% | 8.48 +17.84% | |
Debt-to-Equity Ratio | 1.30 -10.07% | 1.44 +3.25% | 1.40 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.40 -25.24% | 0.53 +0.94% | 0.53 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow